BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-6.91%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$488M
AUM Growth
+$488M
(-12%)
Cap. Flow
-$19.4M
Cap. Flow
% of AUM
-3.97%
Top 10 Holdings %
Top 10 Hldgs %
32.78%
Holding
126
New
5
Increased
19
Reduced
36
Closed
4
Top Buys
| 1 |
Incyte
INCY
|
$5.96M |
| 2 |
BCR
CR Bard Inc.
BCR
|
$5.86M |
| 3 |
Danaher
DHR
|
$5.76M |
| 4 |
AKRX
Akorn, Inc.
AKRX
|
$4.54M |
| 5 |
Edwards Lifesciences
EW
|
$3.75M |
Top Sells
| 1 |
Cardinal Health
CAH
|
$6.78M |
| 2 |
Illumina
ILMN
|
$5.21M |
| 3 |
AMSG
Amsurg Corp
AMSG
|
$4.79M |
| 4 |
Stryker
SYK
|
$3.04M |
| 5 |
Cigna
CI
|
$2.93M |
Sector Composition
| 1 | Healthcare | 91.87% |
| 2 | Financials | 0.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
26
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $6.04M | 1.24% |
49,400
| – | – |
|
27
Vertex Pharmaceuticals
VRTX
$102B
| $5.97M | 1.22% |
81,000
-4,000
| -5% | -$295K |
|
|
28
Danaher
DHR
$143B
| $5.76M | 1.18% |
+83,472
| New | +$5.76M |
|
29
Intuitive Surgical
ISRG
$158B
| $5.71M | 1.17% |
81,000
-27,000
| -25% | -$1.9M |
|
30
BioMarin Pharmaceuticals
BMRN
$11.3B
| $5.39M | 1.1% |
65,000
| – | – |
|
|
ABMD
31
DELISTED
Abiomed Inc
ABMD
| $5.08M | 1.04% |
45,050
-10,400
| -19% | -$1.17M |
|
|
32
Cigna
CI
$80.2B
| $5.03M | 1.03% |
37,722
-22,000
| -37% | -$2.93M |
|
33
Coherus Oncology, Inc. Common Stock
CHRS
$138M
| $4.93M | 1.01% |
175,000
-27,000
| -13% | -$760K |
|
|
CERN
34
DELISTED
Cerner Corp
CERN
| $4.67M | 0.96% |
98,500
| – | – |
|
|
ARIA
35
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $4.67M | 0.96% |
375,000
-120,000
| -24% | -$1.49M |
|
36
Johnson & Johnson
JNJ
$429B
| $4.38M | 0.9% |
38,000
-12,000
| -24% | -$1.38M |
|
37
Ionis Pharmaceuticals
IONS
$9.64B
| $4.35M | 0.89% |
91,000
-17,000
| -16% | -$813K |
|
|
SHPG
38
DELISTED
Shire pic
SHPG
| $4.09M | 0.84% |
24,000
-14,090
| -37% | -$2.4M |
|
|
MNK
39
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $4.03M | 0.82% |
80,800
| – | – |
|
40
Cooper Companies
COO
$13.3B
| $3.5M | 0.72% |
80,000
-14,000
| -15% | -$612K |
|
|
ESRX
41
DELISTED
Express Scripts Holding Company
ESRX
| $3.41M | 0.7% |
49,500
| – | – |
|
42
McKesson
MCK
$85.9B
| $3.37M | 0.69% |
24,000
| – | – |
|
|
EGRX
43
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.23M | 0.66% |
40,700
+11,700
| +40% | +$928K |
|
44
Humana
HUM
$37.5B
| $3.16M | 0.65% |
15,500
+4,700
| +44% | +$959K |
|
45
Halozyme
HALO
$8.75B
| $3.14M | 0.64% |
318,000
| – | – |
|
46
Ultragenyx Pharmaceutical
RARE
$3.04B
| $3.02M | 0.62% |
43,000
| – | – |
|
47
Elevance Health
ELV
$72.4B
| $2.96M | 0.61% |
20,600
| – | – |
|
48
Neurocrine Biosciences
NBIX
$13.5B
| $2.9M | 0.59% |
75,000
+17,000
| +29% | +$658K |
|
|
ZLTQ
49
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $2.61M | 0.53% |
60,000
| – | – |
|
50
Eli Lilly
LLY
$661B
| $2.57M | 0.53% |
35,000
| – | – |
|